The SLC2A1 gene gives instructions for a protein that carries glucose, the body’s main fuel, into the brain and other tissues. This gene plays an important role in keeping brain cells supplied with energy. When it does not work well, some people develop GLUT1 deficiency, which can cause seizures, movement problems, headaches, or learning and developmental differences. Symptoms can vary from person to person.
What is a gene?
Genes are stretches of DNA that provide instructions your cells use to make molecules or regulate processes in the body. Some genes carry the code for proteins, the parts of cells that do much of the work. Others mainly help determine when certain processes happen, where they occur, and how active they are. Taken together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. For a closer look at this topic, you can find more in the LearnHub.
Overview
SLC2A1Gene function
What if the gene works
The SLC2A1 gene helps move glucose, a basic fuel, from the blood into many cells. This is especially important for carrying glucose into the brain.
Risk
What if the gene does not work
Variants in the SLC2A1 gene can reduce glucose transport into the brain, causing GLUT1 deficiency syndrome, with seizures, developmental differences, and movement problems. Milder to more severe variants may shape when symptoms begin and how strongly they affect daily life.
Treatment
What does that mean for your treatment
A pathogenic variant in the SLC2A1 gene usually makes ketogenic diet therapy the key treatment, because ketones can help fuel the brain when glucose transport is reduced. Modified Atkins or related ketogenic plans may also be used. Symptom medicines, including antiseizure drugs, can still be added, but they do not replace this treatment approach.
Conditions associated with SLC2A1
Gene function
What if the gene works
Many tissues need a constant stream of glucose, a main sugar fuel, to keep working. Your cells rely on the SLC2A1 gene to move that fuel across cell membranes. Understanding what the SLC2A1 gene does in the body helps explain how the brain and other tissues keep a steady energy supply.
The SLC2A1 gene makes a transport protein that moves glucose from the blood into many cells. This gives cells a steady source of fuel for routine activity.
Its protein helps glucose cross the blood-brain barrier, the protective lining between the blood and brain. This supports the brain’s constant energy needs throughout the day.
This transporter works in a largely constant way, rather than switching on only after meals. That helps tissues with ongoing energy demands take in glucose even between meals.
What is a variant?
A variant is a small difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some cases, though, a variant changes how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC2A1 gene can alter the GLUT1 transport protein, changing its shape, stability, or amount so it moves less glucose across cell surfaces. This helps explain how SLC2A1 gene variants affect glucose transport. Milder variants may leave partial activity, while more disruptive variants can sharply reduce transport or stop the protein from reaching the cell surface. In GLUT1 deficiency syndrome, that difference can influence how early features appear and how marked they are.
How variants are linked to conditions
Pathogenic variants in the SLC2A1 gene cause GLUT1 deficiency syndrome, a condition linked to seizures, developmental delay, learning difficulties, and movement problems that may begin in infancy or childhood. In some people, an SLC2A1 gene variant and GLUT1 deficiency syndrome are first recognized because of exercise-triggered involuntary movements rather than seizures. Symptoms and severity can vary widely, even within the same family.
A variant is not necessarily a diagnosis
Gene variants are a usual part of human biology and are common across the general population. Most have no direct impact on health and simply reflect normal human diversity. For many genes, carrying a variant connected with a condition suggests a possible association rather than a confirmed diagnosis, especially when several genes and environmental factors also contribute. In some situations, though, one well characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SLC2A1, risk is mainly linked to whether you carry a disease-causing gene change, which may be inherited or happen for the first time in a child. There is not enough evidence that lifestyle changes lower the chance of having this condition. In people already living with it, fasting or long gaps between meals can make symptoms worse.
Inheritance of SLC2A1 variants
The inheritance of SLC2A1 gene variants can differ by the specific SLC2A1-related condition, but the best known pattern is autosomal dominant. In that setting, a parent carrying a disease-causing variant in the SLC2A1 gene can pass it to a child with a 50% chance in each pregnancy. Some people with an SLC2A1-related condition have a new (de novo) variant, meaning it was not inherited from either parent. Rarely, certain SLC2A1-related conditions have also been reported with autosomal recessive inheritance.
What does my SLC2A1 result mean for my family?
For SLC2A1, the main family pattern is dominant, so close relatives such as parents, brothers, sisters, and children may also carry the same change and may want to discuss testing. In many families, each child of someone with a disease-causing SLC2A1 change has a 1 in 2 chance of inheriting it. Some cases happen for the first time in one person, so a parent does not always have the same gene change.
Genetic information
Genetic testing
How you find out about variants
To check for a variant in the SLC2A1 gene, genetic testing uses blood, saliva, or a cheek swab. SLC2A1 genetic testing reads the gene's DNA code and compares it with the usual sequence to look for changes linked to your symptoms or a diagnosis. Results are reviewed alongside your medical history, because some variants do not affect health.
When should I consider getting a genetic test?
Consider genetic testing for the SLC2A1 gene if there is a history of seizures starting in infancy or childhood, movement episodes triggered by exercise, or learning and development delays without a clear cause. Testing may also be useful when these problems run in a family or when doctors suspect GLUT1 deficiency, a condition that limits sugar supply to the brain.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains depends on the condition and the kind of variant involved. How the body functions over time is also shaped by many other factors, including lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information adds context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, moves, or responds to a drug, so the same treatment may work better for one person than for another. These differences are common and can influence how much benefit someone gets or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics studies how genetic differences affect responses to medications. It examines connections between genes and drugs to better understand why treatments do not work the same way in every person. For many medicines, genes help determine how strongly a drug works or how the body processes it. This information can support more informed, individualized treatment decisions. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the SLC2A1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response in routine care. If you have concerns about side effects, medicine changes, or symptoms that worsen after starting a treatment, discuss them with your doctor.
History
The SLC2A1 gene entered medical research in the 1980s, when scientists isolated and mapped one of the first human glucose transporter genes. In 1985, researchers described its sequence, giving genetics a clearer view of how cells take up sugar from the blood. Building on this early work, doctors later connected changes in the SLC2A1 gene with a childhood neurologic condition now called GLUT1 deficiency syndrome. That link, reported in the early 1990s, helped explain why some children developed seizures, movement problems, or learning difficulties despite normal routine testing. Over time, descriptions became more precise as genetic testing improved and more affected families were identified. These milestones made the SLC2A1 gene an important part of the history of neurologic genetics and rare disease diagnosis.